NCT01069367View on ClinicalTrials.gov

Open-label, Uncontrolled Postmarketing Study of Cell-derived A/H1N1 Influenza HA Vaccine in Japanese Elderly Subjects

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

April 30, 2010

Study Completion Date

April 30, 2010

Conditions
Swine-Origin Influenza A H1N1 Virus
Interventions
BIOLOGICAL

Emulsion, Cell Culture-based, influenza HA vaccine H1N1

Cell-derived A/H1N1 influenza HA vaccine (0.25 mL as injection volume)

Trial Locations (1)

Unknown

CPC Clinic, Medipolis Medical Research Institute, Kagoshima

Sponsors

Lead Sponsor

Novartis Vaccines
All Listed Sponsors
lead

Novartis Vaccines

INDUSTRY

NCT01069367 - Open-label, Uncontrolled Postmarketing Study of Cell-derived A/H1N1 Influenza HA Vaccine in Japanese Elderly Subjects | Biotech Hunter | Biotech Hunter